Antiviral clinical trials taking place in Cleveland
By: Sylvia Rose
Posted: Mar 21, 2020 10:48 PM EDT

-
3:00
New South Bend downtown Kosher grocery store to hold open house...
-
1:49
Armed Robbery suspect crashes into river after pursuit in Berrien...
-
2:31
Coalition for Democracy holds vigil in honor of victims of gun...
-
6:20
Hispanic Heritage Month 2025 marked by celebrations of culture...
-
4:16
Notre Dame offense shows some promise despite loss to Texas A&M
-
2:50
SJCPD exhumes body of 40-year-old cold case victim
-
2:35
Notre Dame’s defense under fire after 41– 40 loss to Texas...
-
2:28
Police investigating after shots fired incident in Eddy Street...
-
1:27
Warm and dry this week, rain chance this weekend
-
0:59
Groundbreaking for phase two of ’The Cascade’
-
0:54
’Holy War’ matchup off the field in annual Hunger Bowl
-
5:59
Man attempts to swim the Lake Wawasee shoreline
CLEVELAND, Ohio – University Hospitals in Cleveland are taking the next step in fighting COVID-19, securing two clinical trials that will provide an antiviral drug to adults who have been hospitalized with pneumonia due to the virus.
Leaders of the study are hoping to test around 1000 people nationwide.
"Because there's no other treatment now so it's really exciting to see a drug that could hit the virus itself, not just supportive care," said Dr. Grace McComsey, a doctor at University Hospitals.
The trial should provide information on whether the drug can help lower fevers and normalize oxygen saturation in patients.
The drug is federally regulated and was safely tested on more than 500 people during the Ebola outbreak.
Sign up for the ABC 57 Newsletter